Ergoteles LLC Pliant Therapeutics, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.67 - $24.23 $602,555 - $1.9 Million	-78,560 Reduced 72.41%	29,928 $625,000
Q2 2022 Aug 12, 2022	BUY	$4.11 - $8.75 $445,885 - $949,270	108,488 New	108,488 $869,000
Q1 2022 May 13, 2022	SELL	$7.01 - $14.1 $73,605 - $148,050	-10,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $128,835 - $191,730	10,500 New	10,500 $142,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.